(Q28299333)

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Inhibition of Aldosterone Production by an Atrial Extract

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide levels in cor pulmonale and in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

A C type natriuretic peptide is a vasodilator in vivo and in vitro in the common dogfish.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Inhibition of aldosterone biosynthesis by atriopeptins in rat adrenal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

The protein kinase domain of the ANP receptor is required for signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Purification and sequence analysis of bioactive atrial peptides (atriopeptins)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Guanylin: an endogenous activator of intestinal guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide upregulates vascular endothelin type B receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptides are potent dilators of shark vascular smooth muscle.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-Type natriuretic peptide is a growth inhibitor of rat vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide inhibits intimal thickening after vascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Structural requirements of C-type natriuretic peptide for elevation of cyclic GMP in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Detection of C-type natriuretic peptide in human circulation and marked increase of plasma CNP level in septic shock patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Effect of porcine brain natriuretic peptide (pBNP) on human adrenocortical steroidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Direct inhibitory effect of atriopeptin III on renin release in primate kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide immunoreactivity in human breast vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Hypothalamic effects of C-type natriuretic Peptide on luteinizing hormone secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

ANP-(7-23) stimulates a DHP-sensitive Ca2+ conductance and reduces cellular cAMP via a cGMP-independent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial natriuretic polypeptide as a novel antigrowth factor of endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide (CNP) is the major natriuretic peptide in human cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Role of endopeptidase-24.11 in the inactivation of atrial natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Receptors for C-type natriuretic peptide in cultured rat glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Cloning and sequence analysis of a cDNA encoding a precursor for rat C-type natriuretic peptide (CNP)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Inhibition by atrial and brain natriuretic peptides of endothelin-1 secretion after stimulation with angiotensin II and thrombin of cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide inhibits thrombin- and angiotensin II-stimulated endothelin release via cyclic guanosine 3',5'-monophosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Selective Activation of the B Natriuretic Peptide Receptor by C-Type Natriuretic Peptide (CNP)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Conservation of the kinaselike regulatory domain is essential for activation of the natriuretic peptide receptor guanylyl cyclases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide (CNP) in rats and humans

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Vascular natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial and brain natriuretic peptides: a dual natriuretic peptide system potentially involved in circulatory homeostasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Cytokine regulation of endothelial cell function.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Physiological role of silent receptors of atrial natriuretic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Structural and biochemical identity of retinal rod outer segment membrane guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Presence of C-type natriuretic peptide in human kidney and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Cyclic guanosine monophosphate production in the pituitary: stimulation by C-type natriuretic peptide and inhibition by gonadotropin-releasing hormone in alpha T3-1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Brain natriuretic peptide administered to man: actions and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial natriuretic factor inhibits ACTH stimulated aldosterone, but not cortisol, secretion in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

N-terminally extended form of C-type natriuretic peptide (CNP-53) identified in porcine brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Characterization of immunoreactive human C-type natriuretic peptide in brain and heart

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Effects of brain natriuretic peptide and C-type natriuretic peptide infusion on urine flow and jejunal absorption in anesthetized dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Inhibition by atrial natriuretic peptide of endothelin-1-stimulated proliferation of vascular smooth-muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Natriuretic peptide receptor mRNAs in the rat and human heart

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Human C-type natriuretic peptide. Characterization of the gene and peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Polypeptide growth factors and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

CNP-22 stimulates, rather than inhibits, water drinking in the rat: evidence for a unique biological action of the C-type natriuretic peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide mediates the hypothalamic actions of the natriuretic peptides to inhibit luteinizing hormone secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Decreased density of binding sites for atrial natriuretic peptide on platelets of patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Molecular cloning of a retina-specific membrane guanylyl cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-beta. Possible existence of "vascular natriuretic peptide system"

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells--evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Isolation of high-molecular-weight C-type natriuretic peptide from the heart of a cartilaginous fish (European dogfish, Scyliorhinus canicula).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Evidence for C-type natriuretic peptide production in the rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Gene and precursor structure of porcine C-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Gene and precursor structures of human C-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

HS-142-1, a novel non-peptide ANP antagonist, blocks the cyclic GMP production elicited by natriuretic peptides in PC12 and NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Elevated plasma C-type natriuretic peptide concentrations in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide in the human central nervous system: distribution and molecular form.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

C-type natriuretic peptide neuromodulates independently of guanylyl cyclase activation

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Distribution and characterization of immunoreactive porcine C-type natriuretic peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Detection of C-type natriuretic peptide (CNP) transcript in the rat heart and immune organs.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Natriuretic peptide system in human heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Vasonatrin peptide: a unique synthetic natriuretic and vasorelaxing peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Atrial natriuretic peptide and C-type natriuretic peptide in spontaneously hypertensive rats and their vasorelaxing actions in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021

Differential regional expression of three natriuretic peptide receptor genes within primate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2896%2900110-6

7 January 2021